Blood-brain barrier permeation: molecular parameters governing passive diffusion.
about
Identification of novel functional inhibitors of acid sphingomyelinaseMultifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingThe blood-brain barrier: bottleneck in brain drug developmentMedications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infantsLB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potentialBlood brain barrier: a challenge for effectual therapy of brain tumorsA novel GTP-binding inhibitor, FX2149, attenuates LRRK2 toxicity in Parkinson's disease modelsBlood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative DiseasesUltrasound-induced blood-brain barrier openingMulti-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study.Optimization of the ultrasound-induced blood-brain barrier openingThe pK(a) Distribution of Drugs: Application to Drug DiscoveryDifferential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.Modification of permeability transition pore arginine(s) by phenylglyoxal derivatives in isolated mitochondria and mammalian cells. Structure-function relationship of arginine ligands.Paclitaxel succinate analogs: Anionic and amide introduction as a strategy to impart blood-brain barrier permeability.The acid-base profile of a contemporary set of drugs: implications for drug discovery.PET radiotracers: crossing the blood-brain barrier and surviving metabolismRetention study of some cation-type compounds using bile acid sodium salts as ion pairing agents in liquid chromatography.Pathways for small molecule delivery to the central nervous system across the blood-brain barrier.Medicinal chemical properties of successful central nervous system drugsDrug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?Brainpeps: the blood-brain barrier peptide database.Exploring the P-glycoprotein binding cavity with polyoxyethylene alkyl ethers.Physicochemical selectivity of the BBB microenvironment governing passive diffusion--matching with a porcine brain lipid extract artificial membrane permeability model.Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizuresAntioxidants as treatment for neurodegenerative disorders.A systematic investigation of quaternary ammonium ions as asymmetric phase-transfer catalysts. Application of quantitative structure activity/selectivity relationships.Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activityBlood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.P-glycoprotein-ATPase modulation: the molecular mechanisms.MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist.Cellular quantitative structure-activity relationship (Cell-QSAR): conceptual dissection of receptor binding and intracellular disposition in antifilarial activities of Selwood antimycins.A Genetic Algorithm Based Support Vector Machine Model for Blood-Brain Barrier Penetration Prediction.Intravenous HOE-642 reduces brain edema and Na uptake in the rat permanent middle cerebral artery occlusion model of stroke: evidence for participation of the blood-brain barrier Na/H exchanger.Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding.CNS pharmacokinetics of antifungal agents.Adult human dental pulp stem cells promote blood-brain barrier permeability through vascular endothelial growth factor-a expression.Modeling kinetics of subcellular disposition of chemicals.Alzheimer's disease drug development and the problem of the blood-brain barrier.
P2860
Q21003953-725F14FC-C194-4099-A2DD-88FB4F71B32DQ21223671-47B5BFEB-F483-48D8-8604-E16DB9AE680AQ22336985-C00E424B-E677-462C-819D-68EF4D8D53FAQ24201013-01AD881B-7B5F-4FAF-B86A-493D1E139937Q26865711-A92375E2-28EB-4FB3-9500-A3C9F03ED0AAQ28081947-3FBECD0C-D3CF-40B3-8A3C-447E36DFE7F8Q28545100-014E9B5F-6457-4654-8C62-57AB31BF440BQ28829017-760A514B-8352-404E-8507-A29DEF6256CAQ30437732-A257C2D9-1DD8-46BC-B91B-A9D6879B8EB9Q30441159-51F79193-E323-42F5-9E06-FDC362E3E13BQ30458489-89DCFF4F-F833-47F9-B8D3-8DD73F1DBFE4Q30490660-8057A3F3-0578-4E76-B0B2-8E8769B19A42Q32178363-3CB2E6E6-BA18-48AB-ADEA-D3A0DF2EABDBQ33211203-5954FD5F-D391-427C-9187-4AB0A853CC71Q33377332-8C443C9B-5A75-45ED-920A-4E0AE8CBBF98Q33520009-2ED24E49-169F-4FD1-93EB-6DE1053FDAB6Q33585028-C74F57B3-6FC3-44DD-9E72-72D434D03C86Q33723168-07B13D4D-0798-4576-B15B-7122735C0759Q33783748-73E65B02-276D-4EDA-97FF-EE6B32804CFEQ33946968-850C1777-69ED-405D-9771-D95966834598Q33995372-31F33BC5-6343-4F2A-813A-65CC1ECE168FQ34243408-8E1D027C-02B0-4DA7-AFDD-AE2B2CEB4712Q34388732-A6892BA5-A520-41A7-87B1-C2308F61CFB1Q34556508-49BE1347-DAE4-400B-9CA2-61155BAECBEDQ34722445-7477563D-F22C-409E-BACD-700C3C8DBCC0Q34823865-3981E749-BD46-4A7C-936A-E1AF4A44CC20Q34974866-78963ADB-69CE-4529-966E-FBC8D0882B2DQ35023125-1FC0BF5B-E837-4637-A81D-2FDAC1573CB3Q35052079-E0919E3D-3E92-43DF-8F87-46B21263AD33Q35621061-484AC92B-4E9A-4235-A7EA-DFDE4589857BQ35843851-C62162EF-CDC5-4A7F-BEDA-C4C9359D2243Q35869282-B8917109-EDEA-4286-8497-7088A3CC7F99Q35917151-2833678F-AA4A-4091-8C1B-B9F0E512E9CFQ36172940-86A966A8-8A59-4428-8EDA-8095276F1C9DQ36587070-64690980-54FA-4C3C-827A-4F7D3CEDEB37Q36609763-D664EA49-FE54-4DD7-ADF9-DBAFCE1DDFC8Q36909333-1AEFF4E0-D4AC-4268-A264-B36705AE4923Q37006251-774159F9-9A6C-4CDB-9104-4622B45CACFBQ37194304-0A4309E2-3EDB-4891-90E8-58371CA340C0Q37374635-EF71F055-ADE1-4683-86A0-C3D6E6175D6A
P2860
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@ast
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@en
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@nl
type
label
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@ast
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@en
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@nl
prefLabel
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@ast
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@en
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@nl
P2093
P356
P1476
Blood-brain barrier permeation: molecular parameters governing passive diffusion.
@en
P2093
Gottschlich R
P2888
P304
P356
10.1007/S002329900434
P577
1998-10-01T00:00:00Z
P5875
P6179
1028322964